Concepedia

Author

Ines De Pauw

University of AntwerpORCID

Also Known As

I. De Pauw, I. de Pauw, Ines De Pauw, Miller, Robyn

27

Publications

574

Citations

15

H-Index

16

Concepts

All Affiliations

University of AntwerpAntwerp University HospitalStatistics Belgium
ID

About

Ines De Pauw is an author at University of Antwerp specializing in tumor biology, tumor microenvironment, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

55

2

Cell Biology

2

2

36

3

Immunology

2

2

37

4

Pathology

2

2

37

5

Pharmacology

1

1

18

Ines De Pauw

×

13

Publications

327

Citations

12

H-Index

YearCitations

Enzymes Catalyzing the TCA- and Urea Cycle Influence the Matrix Composition of Biofilms Formed by Methicillin-Resistant Staphylococcus aureus USA300

Sarah De Backer, Julia Sabirova, Ines De Pauw,

Microorganisms

2018

43

Simultaneous targeting of <scp>EGFR</scp>,<scp> HER</scp>2, and <scp>HER</scp>4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines

Ines De Pauw, Filip Lardon, Jolien Van den Bossche,

Molecular Oncology

2018

42

Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status

Hasan Baysal, Ines De Pauw, Hannah Zaryouh,

British Journal of Cancer

2020

39

Prognostic implications of cellular senescence in resected non-small cell lung cancer

Andreas Domen, Christophe Deben, Ines De Pauw,

Translational Lung Cancer Research

2022

36

<i>In vitro</i> study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53

Jolien Van den Bossche, Christophe Deben, Ines De Pauw,

Molecular Oncology

2019

27

The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines

Carolien Boeckx, Jolien Van den Bossche, Ines De Pauw,

BMC Research Notes

2015

23

The prognostic impact of the immune signature in head and neck squamous cell carcinoma

Hasan Baysal, Vasiliki Siozopoulou, Hannah Zaryouh,

Frontiers in Immunology

2022

19

A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein

Ellen Van Damme, Pravien Abeywickrema, Yanting Yin,

Nature

2025

19

Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines

Ines De Pauw, An Wouters, Jolien Van den Bossche,

Cancer Biotherapy and Radiopharmaceuticals

2017

18

The Role of Akt in Acquired Cetuximab Resistant Head and Neck Squamous Cell Carcinoma: An In Vitro Study on a Novel Combination Strategy

Hannah Zaryouh, Ines De Pauw, Hasan Baysal,

Frontiers in Oncology

2021

18

Page 1